Name and title of director and officer: Dave Girouard, Former Chief Executive Officer, Executive Chairman Date of adoption: September 9, 2026 Duration of the trading arrangement: Through November 30, 2027, or earlier if all transactions under the trading arrangement are completed Aggregate number of securities to be sold from time to time: up to 1,490,596 shares of common stock, including up to 1,356,704 shares issuable upon the exercise of outstanding options and up to 133,892 founder shares held through two trusts.
|